Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Minimal residual disease (MRD) refers to a chemotherapy/radiotherapy-surviving leukemia cell population that gives rise to relapse of the disease. The detection of MRD is critical for predicting the outcome and for selecting the intensity of further treatment strategies. The development of various n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Aaron, Abdel-Azim, Nour, Kim, Hye Na, Ruan, Yongsheng, Phan, Valerie, Ogana, Heather, Wang, William, Lee, Rachel, Gang, Eun Ji, Khazal, Sajad, Kim, Yong-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037356/
https://www.ncbi.nlm.nih.gov/pubmed/32033444
http://dx.doi.org/10.3390/ijms21031054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037356/
https://www.ncbi.nlm.nih.gov/pubmed/32033444
http://dx.doi.org/10.3390/ijms21031054

Ejemplares similares